American Century Companies’s Avidity Biosciences RNAM Stock Holding History

American Century Companies's RNAM Position: Q1 2026 in Review

American Century Companies sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 7,985 shares — an estimated $576K sold.

American Century Companies first reported a position in RNAM in Q4 2023 and held it in 5 quarters. The position peaked at $6.73M in Q2 2024. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

• American Century Companies reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
• American Century Companies sold 7,985 Avidity Biosciences shares in Q1 2026, an estimated $576K.
• American Century Companies first reported a position in Avidity Biosciences in Q4 2023 and held it in 5 quarters.
• American Century Companies's Avidity Biosciences position peaked at $6.73M in Q2 2024.
• 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.